In recent times, CSF levels of Aβ42, total tau, and p-tau have been linked to clinical outcomes in investigations of healthy older people with amnestic mild cognitive impairment or mild Alzheimer's disease. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.